tiprankstipranks
Telo Genomics (TSE:TELO)
:TELO
Canadian Market
Holding TSE:TELO?
Track your performance easily

Telo Genomics Corp (TELO) Financial Statements

21 Followers

Telo Genomics Corp Financial Overview

Telo Genomics Corp's market cap is currently ―. The company's EPS TTM is C$-0.035; its P/E ratio is ―; Telo Genomics Corp is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -552.76K$ -599.25K$ -606.06K$ -835.14K$ -672.55K
EBITDA$ -547.35K$ -590.44K$ -596.19K$ -824.60K$ -662.24K
Net Income Common Stockholders$ -552.76K$ -599.25K$ -606.06K$ -835.14K$ -672.55K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 328.27K$ 796.02K$ 690.88K$ 1.30M$ 1.98M
Total Assets$ 440.18K$ 965.64K$ 856.53K$ 1.53M$ 2.20M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 403.06K$ 375.59K$ 257.05K$ 321.36K$ 221.14K
Stockholders Equity$ 37.12K$ 590.06K$ 599.49K$ 1.21M$ 1.98M
Cash Flow-
Free Cash Flow$ -467.57K$ -506.70K$ -581.77K$ -682.63K$ -693.18K
Operating Cash Flow$ -467.57K$ -504.38K$ -581.77K$ -682.63K$ -690.38K
Investing Cash Flow-$ -2.31K--$ -2.80K
Financing Cash Flow$ -175.00$ 611.83K$ -22.50K-$ -2.28K
Currency in USD

Telo Genomics Corp Earnings and Revenue History

Telo Genomics Corp Debt to Assets

Telo Genomics Corp Cash Flow

Telo Genomics Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis